相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of a PCAF Bromodomain Chemical Probe
Moses Moustakim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Pharmacological Inhibition of Bromodomain Proteins Suppresses Retinal Inflammatory Disease and Downregulates Retinal Th17 Cells
Malihe Eskandarpour et al.
JOURNAL OF IMMUNOLOGY (2017)
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
Lea Bouche et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins
Niall Igoe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development
Victoria Jeffers et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2017)
Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics
Stuart W. Ember et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells
Amy E. Campbell et al.
SKELETAL MUSCLE (2017)
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
Amaury E. Fernandez-Montalvan et al.
ACS CHEMICAL BIOLOGY (2017)
Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation
Julia C. Meier et al.
ACS CHEMICAL BIOLOGY (2017)
Beyond the BET Family: Targeting CBP/p300 with 4-Acyl Pyrroles
Martin Huegle et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Synthesis and evaluation of novel dual BRD4/HDAC inhibitors
Seika Amemiya et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
Peiling Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Abstract A49: Clinically efficacy of the BET bromodomain inhibitor TEN-010 in an open-label substudy with patients with documented NUT-midline carcinoma (NMC)
Geoffrey I. Shapiro et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
Gong-Quan Li et al.
ONCOTARGET (2016)
A switch in metabolic phenotype in vemurafenib-resistant melanoma cells to increased amino acid dependence serves as an alternate mechanism for survival
Deeba N. Syed et al.
CANCER RESEARCH (2016)
BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
Guillaume Andrieu et al.
CANCER RESEARCH (2016)
The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease
Marco Magistri et al.
CURRENT ALZHEIMER RESEARCH (2016)
A phase lb trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors
C. Massard et al.
EUROPEAN JOURNAL OF CANCER (2016)
First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies
S. Postel-Vinay et al.
EUROPEAN JOURNAL OF CANCER (2016)
Overexpression of bromodomain factor 3 in Trypanosoma cruzi (TcBDF3) affects differentiation of the parasite and protects it against bromodomain inhibitors
Victoria Lucia Alonso et al.
FEBS JOURNAL (2016)
Haploinsufficiency of BAZ1B contributes to Williams syndrome through transcriptional dysregulation of neurodevelopmental pathways
Matthew A. Lalli et al.
HUMAN MOLECULAR GENETICS (2016)
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J. Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts
Kerstin Klein et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNFMutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi et al.
CANCER RESEARCH (2015)
A Plasmodium Falciparum Bromodomain Protein Regulates Invasion Gene Expression
Gabrielle A. Josling et al.
CELL HOST & MICROBE (2015)
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
Michela Boi et al.
CLINICAL CANCER RESEARCH (2015)
ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
Yang Luo et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome
Danae Schulz et al.
PLOS BIOLOGY (2015)
BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
Lei Gu et al.
NATURE GENETICS (2015)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
BET bromodomain proteins are required for glioblastoma cell proliferation
Chiara Pastori et al.
EPIGENETICS (2014)
The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells
Stuart J. Gallagher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Duncan A. Hay et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Pietro Ciceri et al.
NATURE CHEMICAL BIOLOGY (2014)
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma
Joydeep Bhadury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Daniela Boehm et al.
CELL CYCLE (2013)
BET bromodomain inhibition suppresses TH17-mediated pathology
Deanna A. Mele et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
Anna C. Belkina et al.
JOURNAL OF IMMUNOLOGY (2013)
BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
Jessica I. Spiltoir et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
ChromoHub: a data hub for navigators of chromatin-mediated signalling
Lihua Liu et al.
BIOINFORMATICS (2012)
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Christopher J. Ott et al.
BLOOD (2012)
Small-Molecule Inhibition of BRDT for Male Contraception
Martin M. Matzuk et al.
CELL (2012)
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
Camellia Banerjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
William W. Lockwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Global histone acetylation levels: Prognostic relevance in patients with renal cell carcinoma
Davit Mosashvilli et al.
CANCER SCIENCE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
Shimin Zhao et al.
SCIENCE (2010)
ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
Marco Ciro et al.
CANCER RESEARCH (2009)
Regulation of Aurora B Expression by the Bromodomain Protein Brd4
Jianxin You et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
A complex t(1;22;11)(q44;q13;q23) translocation causing MLL-p300 fusion gene in therapy-related acute myeloid leukemia
Hiroaki Ohnishi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Mammalian ASH1L is a histone methyl transferase that occupies the transcribed region of active genes
Gregory D. Gregory et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly
Michael Field et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: Preservation of acetylated chromatin
A Nishiyama et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
Selective small molecules blocking HIV-1 Tat and coactivator PCAF association
L Zeng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation
T Nakamura et al.
MOLECULAR CELL (2002)
Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain
A Dorr et al.
EMBO JOURNAL (2002)
Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly
J Nakayam et al.
SCIENCE (2001)
分享论文
